Product Detail
Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride
Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride Product Information
Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96888.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride
CAS No.
-
CAT No.
CS-T-96888
Molecular Formula
C25H45D3ClNO6
Molecular Weight
497.12
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride is the labeled analogue of Octadecanedioic Acid Mono-L-carnitine Ester (O235260), one of the acycarnitines used determine baseline metabolomic profiles to predict cardiovascular events in patients at risk for coronary artery disease."
Synonyms
"(R)-3-Carboxy-2-[(17-carboxy-1-oxoheptadecyl)oxy]-N,N,N-trimethyl-d3-1-propanaminium Chloride; (2R)-3-Carboxy-2-[(17-carboxy-1-oxoheptadecyl)oxy]-N,N,N-trimethyl-d3-1-propanaminium Chloride; (R)-3-((17-Carboxyheptadecanoyl)oxy)-4-(trimethyl-d3-ammonio)but"
Application Notes
"Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride is the labeled analogue of Octadecanedioic Acid Mono-L-carnitine Ester (O235260), one of the acycarnitines used determine baseline metabolomic profiles to predict cardiovascular events in patients at risk for coronary artery disease."
References
"Shah, S.H., et. al.: Am. Heart J., 163, 844 (2012)"